Application of oligonucleotide arrays to high-content genetic analysis.
The scope of single nucleotide polymorphism genotyping for genetic association studies has expanded recently from the use of relatively small numbers of candidate genes and markers, to include hypothesis-free, whole-genome approaches using hundreds of thousands of polymorphisms. The ability to perform such large-scale association studies has been dependant on the development of highly parallel and cost-effective genotyping platforms, of which those based on oligonucleotide arrays have proved to be the most scalable and widely adopted. It is to be expected that the new array-based genotyping methods will not only greatly expand the scope of genetic studies, but, as further content is added to arrays, will also form part of an integrated set of DNA, RNA and proteomic analyses enabling the detailed, multilayered study of complex disease-linked phenotypes.
Gibson
Neil J
NJ
AstraZeneca Pharmaceuticals, 19G9, Mereside, Alderley Park, Macclesfield, SK10 4TG, UK. neil.gibson@astrazeneca.com
D001483:Base Sequence; D004247:DNA / Q000737:chemistry; D008040:Genetic Linkage; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008954:Models, Biological; D025202:Molecular Diagnostic Techniques; D008969:Molecular Sequence Data; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D009841:Oligonucleotides / Q000737:chemistry*; D010641:Phenotype; D011110:Polymorphism, Genetic; D040901:Proteomics / Q000379:methods; D012313:RNA / Q000737:chemistry; D017422:Sequence Analysis, DNA
D009841:Oligonucleotides; D012313:RNA; D004247:DNA